Home › isis
 

Keywords :   


Tag: isis

Genzyme And Isis Announce FDA Approval Of KYNAMRO (Mipomersen Sodium) Injection For The Treatment Of Homozygous Familial Hypercholesterolemia

2013-01-29 19:30:00| drugdiscoveryonline News Articles

Genzyme, a Sanofi company, and Isis Pharmaceuticals Inc. recently announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for KYNAMRO (mipomersen sodium) injection

Tags: treatment approval injection announce

 

Sites : [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24]